BRPI0418374A - derivados de diaza-espiropiperidina como inibidores de transportador 1 de glicina e transportador 2 de glicina - Google Patents
derivados de diaza-espiropiperidina como inibidores de transportador 1 de glicina e transportador 2 de glicinaInfo
- Publication number
- BRPI0418374A BRPI0418374A BRPI0418374-6A BRPI0418374A BRPI0418374A BR PI0418374 A BRPI0418374 A BR PI0418374A BR PI0418374 A BRPI0418374 A BR PI0418374A BR PI0418374 A BRPI0418374 A BR PI0418374A
- Authority
- BR
- Brazil
- Prior art keywords
- lower alkyl
- halogen
- optionally substituted
- group
- glycine transporter
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102000010726 Glycine Plasma Membrane Transport Proteins Human genes 0.000 title 2
- 108010063380 Glycine Plasma Membrane Transport Proteins Proteins 0.000 title 2
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 150000002367 halogens Chemical group 0.000 abstract 5
- 125000001424 substituent group Chemical group 0.000 abstract 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 4
- 239000004471 Glycine Substances 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004404 heteroalkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
Abstract
DERIVADOS DE DIAZA-ESPIROPIREDIDINA COMO INIBIDORES DE TRANSPORTADOR 1 DE GLICINA E TRANSPORTADOR 2 DE GLICINA. A presente invenção refere-se a compostos de fórmula (I) em que A-B é CH~ 2~-CH~ 2~, -CH~ 2~-O-, -O-CH~ 2~-, -CH~ 2~-S-, -S-CH~ 2~-, -CH~ 2~-C(O)-, -C(O)-CH~ 2~-, -N(R¬ 4 ¬)-CH ~2~- ou -CH~ 2 ~-N(R¬ 4 ¬)-; R¬ 1 ¬ é alquila inferior, alquenila inferior, cicloalquila, ou é arila opcionalmente substituída por um ou dois substituintes, selecionados do grupo consistindo em halogênio, ciano, alquila inferior, CF~ 3~, OCF~ 3~ ou alcóxi inferior, ou é heteroalila, opcionalmente substituída por um ou dois substituintes selecionados do grupo consistindo em halogênio, alquila inferior, CF~ 3~ou alcóxi inferior; R¬ 2 ¬ é aquila inferior, cicloalquila, ou é arila, opcionalmente substituída por um ou dois substituintes, selecionado do grupo consistindo em halogênio, alquila inferior, CF~ 3~, alcóxi inferior, ou é heteroalila, opcionalmente substituída por um ou dois substituintes, selecionados do grupo consistindo em halogênio, alquila inferior, CF ~3~ ou alcóxi inferior; ou é heteroarila, opcionalmente substituída por um ou dois substituintes, selecionados do grupo consistindo em halogênio, alquila inferior, CF~ 3~ ou alcóxi inferior; R¬ 3 ¬ é o hidrogênio, alquila inferior ou benzila; R¬ 4 ¬ é hidrogênio ou benzila; n é o 0,1 ou 2; e a sais farmaceuticamente disponíveis destes. Os compostos de formúla I podem se empregados no tratamento de distúrbios neurológicos e neuropsiquiátricos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04100034 | 2004-01-08 | ||
PCT/EP2004/014840 WO2005068462A1 (en) | 2004-01-08 | 2004-12-30 | Diaza-spiropiperidine derivatives as inhibitors of transporter 1 and glycine transporter 2 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0418374A true BRPI0418374A (pt) | 2007-05-22 |
Family
ID=34717284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0418374-6A BRPI0418374A (pt) | 2004-01-08 | 2004-12-30 | derivados de diaza-espiropiperidina como inibidores de transportador 1 de glicina e transportador 2 de glicina |
Country Status (14)
Country | Link |
---|---|
US (1) | US7265126B2 (pt) |
EP (1) | EP1716147B1 (pt) |
JP (1) | JP4527732B2 (pt) |
KR (1) | KR100783836B1 (pt) |
CN (1) | CN100422183C (pt) |
AT (1) | ATE378339T1 (pt) |
AU (1) | AU2004313692B2 (pt) |
BR (1) | BRPI0418374A (pt) |
CA (1) | CA2553938A1 (pt) |
DE (1) | DE602004010186T2 (pt) |
ES (1) | ES2295963T3 (pt) |
PL (1) | PL1716147T3 (pt) |
RU (1) | RU2351599C2 (pt) |
WO (1) | WO2005068462A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8552024B2 (en) * | 2010-08-13 | 2013-10-08 | Hoffman-La Roche Inc. | Azacyclic compounds |
AR092031A1 (es) * | 2012-07-26 | 2015-03-18 | Merck Sharp & Dohme | Inhibidores del canal de potasio medular externo renal |
CA3028752A1 (en) | 2016-07-01 | 2018-01-04 | G1 Therapeutics, Inc. | Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines |
SG11202101807SA (en) | 2018-08-24 | 2021-03-30 | G1 Therapeutics Inc | Improved synthesis of 1,4-diazaspiro[5.5]undecan-3-one |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE897058A (fr) * | 1982-06-25 | 1983-12-16 | Sandoz Sa | Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer |
BE900003A (fr) * | 1983-06-27 | 1984-12-27 | Sandoz Sa | Derives du spirosuccinimide utilisables comme medicaments. |
IL107881A0 (en) * | 1992-12-05 | 1994-04-12 | Fisons Corp | Furanone derivatives and pharmaceutical compositions containing them |
HUP9600928A3 (en) * | 1996-04-10 | 1999-03-29 | Richter Gedeon Vegyeszet | Use of spiro[2h-1-benzopyran-2,4'-piperidin]-4(3h)-one derivatives for the preparation of pharmaceutical compositions treating dementia, novel derivatives and process for their preparation |
TWI243173B (en) * | 1999-11-17 | 2005-11-11 | Akzo Nobel Nv | Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives |
WO2003053942A1 (en) * | 2001-12-20 | 2003-07-03 | H. Lundbeck A/S | Aryloxyphenyl and arylsulfanylphenyl derivatives |
-
2004
- 2004-12-30 PL PL04804425T patent/PL1716147T3/pl unknown
- 2004-12-30 WO PCT/EP2004/014840 patent/WO2005068462A1/en active IP Right Grant
- 2004-12-30 JP JP2006548180A patent/JP4527732B2/ja not_active Expired - Fee Related
- 2004-12-30 CN CNB2004800397203A patent/CN100422183C/zh not_active Expired - Fee Related
- 2004-12-30 KR KR1020067013613A patent/KR100783836B1/ko not_active IP Right Cessation
- 2004-12-30 EP EP04804425A patent/EP1716147B1/en active Active
- 2004-12-30 DE DE602004010186T patent/DE602004010186T2/de active Active
- 2004-12-30 CA CA002553938A patent/CA2553938A1/en not_active Abandoned
- 2004-12-30 ES ES04804425T patent/ES2295963T3/es active Active
- 2004-12-30 BR BRPI0418374-6A patent/BRPI0418374A/pt not_active Application Discontinuation
- 2004-12-30 AT AT04804425T patent/ATE378339T1/de active
- 2004-12-30 RU RU2006128612/04A patent/RU2351599C2/ru not_active IP Right Cessation
- 2004-12-30 AU AU2004313692A patent/AU2004313692B2/en not_active Ceased
-
2005
- 2005-01-03 US US11/028,125 patent/US7265126B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN100422183C (zh) | 2008-10-01 |
US7265126B2 (en) | 2007-09-04 |
RU2006128612A (ru) | 2008-02-20 |
RU2351599C2 (ru) | 2009-04-10 |
EP1716147B1 (en) | 2007-11-14 |
PL1716147T3 (pl) | 2008-03-31 |
AU2004313692B2 (en) | 2011-07-28 |
DE602004010186T2 (de) | 2008-07-03 |
CA2553938A1 (en) | 2005-07-28 |
ATE378339T1 (de) | 2007-11-15 |
AU2004313692A1 (en) | 2005-07-28 |
JP2007517815A (ja) | 2007-07-05 |
KR20060112684A (ko) | 2006-11-01 |
US20050154000A1 (en) | 2005-07-14 |
ES2295963T3 (es) | 2008-04-16 |
JP4527732B2 (ja) | 2010-08-18 |
CN1902203A (zh) | 2007-01-24 |
DE602004010186D1 (de) | 2007-12-27 |
KR100783836B1 (ko) | 2007-12-10 |
WO2005068462A1 (en) | 2005-07-28 |
EP1716147A1 (en) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0507903A (pt) | derivados de quinazolina e composição farmacêutica compreendendo os mesmos | |
EA200870358A1 (ru) | 2-(циклический амино) пиримидоновые производные в качестве ингибиторов tpk1 | |
EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
BRPI0519794A2 (pt) | derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos | |
ATE515505T1 (de) | Heterocyclische fxr-bindende verbindungen | |
EA200900066A1 (ru) | Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил) -d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета | |
DE602005023544D1 (de) | Angiogeneseinhibitoren | |
BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
BRPI0718966B8 (pt) | composto, composição farmacêutica, inibidor plk1 e agente antitumoral | |
DE602006007012D1 (de) | Pyridinderivate als dipeptedyl-peptidase-hemmer | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
DE602006010540D1 (de) | (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor | |
MY148988A (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
TNSN07469A1 (en) | N-(heteroaryl) -1- heteroarylalkyl -1h-indole-2- carboxamide derivatives, preparation and use thereof | |
DE502005006955D1 (de) | N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl-bernsteinsäureamid derivate und verwandte verbindungen als ppar-liganden (peroxisomen-proliferatoren-aktivierte rezeptoren) zur behandlung von hyperlipidämie und diabetes | |
ATE543803T1 (de) | 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren | |
ATE396183T1 (de) | Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors | |
EA200801536A1 (ru) | Новые тиенопирсульфоновые производные | |
ATE466007T1 (de) | 5-substituierte indol-2-carbonsäureamidderivate | |
ATE435223T1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
ATE380816T1 (de) | Substituierte imidazopyrimidine zur prävention und behandlung von krebs | |
EA200700707A1 (ru) | Производные 2-ациламинотиазола |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |